Reflector Bio, a New York-based biotechnology startup developing artificial intelligence models for drug discovery, has emerged from stealth with a... Read More ...
In vivo CAR-T therapy requires durable, yet transient CAR expression coupled with efficient, T cell-specific delivery. This webinar will focus on how innovations in RNA design and next-generation ...
Epigenetic reprogramming is rewriting what we thought we knew about permanent vision loss.
The trial plans to enrol around 252 patients across at least six sites in US where Lyme disease is endemic.
Immunotherapy with checkpoint inhibitors has revolutionized cancer therapy and enabled considerable therapeutic advances for ...
Lillian Chiang, Founder and CEO of Doylestown, Pennsylvania-based Evrys Bio, has received the Timothy M. Block Biotech Impact ...
An in vitro study found that five plant compounds impaired efflux-pump activity and reduced P. aeruginosa PAO1 biofilm formation, with salvianolic acid A producing the strongest effects.
Biological clocks coordinate the spatiotemporal organization of metabolism with diurnal time cues, and bulk-tissue RNA ...
Arbor Biotechnologies, Inc., a biotechnology company discovering and developing the next generation of genetic medicines, ...
("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage biotechnology company developing gene therapies designed to ...
AI maps gene switches to steer dodo revival via pigeon DNA editing Ai-pinpointed DNA switches chart a path to sculpt ...
The collaboration will combine Sanofi’s mRNA drug candidates with ScionxBio’s AI-driven TERA platform to develop ...